Catherine A. Brady
Birmingham Research Park
Birmingham, ENG, United Kingdom
Birmingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
P2X7R-mediated IL-1β release by human brain tissue: the impact of CNS-penetrant potential therapeutics.
Journal: Brain : a journal of neurology
Published: April 22, 2025
Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?
Journal: British journal of pharmacology
Published: December 02, 2024
Design, synthesis and evaluation of tryptophan analogues as tool compounds to study IDO1 activity.
Journal: RSC chemical biology
Published: November 17, 2020
Ex vivo modelling of PD-1/PD-L1 immune checkpoint blockade under acute, chronic, and exhaustion-like conditions of T-cell stimulation.
Journal: Scientific reports
Published: December 19, 2019
CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome.
Journal: The Journal of pharmacology and experimental therapeutics
Published: June 26, 2019
Inosine Acedoben Dimepranol promotes an early and sustained increase in the natural killer cell component of circulating lymphocytes: A clinical trial supporting anti-viral indications.
Journal: International immunopharmacology
Published: October 06, 2016
The discovery of diazepinone-based 5-HT3 receptor partial agonists.
Journal: Bioorganic & medicinal chemistry letters
Published: January 23, 2014
5-Chloroindole: a potent allosteric modulator of the 5-HT₃ receptor.
Journal: British journal of pharmacology
Published: October 25, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026